Think Bioscience Inc.
The University of Colorado Connection
Think Bioscience is a 抖阴传媒在线-based synthetic biology company with strong roots at CU 抖阴传媒在线. The company was spun out of 's lab (CU 抖阴传媒在线 Department of Chemical and Biological Engineering and BioFrontiers Institute), where its foundational technology, leveraging microbial systems to discover small-molecule drugs for previously 鈥渦ndruggable鈥 targets, was developed. Its lead programs, including inhibitors of PTP1B, emerged directly from this academic research.
Funding Status and Investment Opportunities
- Industry Applications: Health and Wellness, Biotech鈥, Therapeutics
- Funding Stage: Series B
- Contact for Investment Inquiries: , jfox@thinkbioscience.com
In the News
- Think Bioscience raises $55M in oversubscribed Series A (2026)
- Think Bioscience, a CU 抖阴传媒在线 spinout, raises $26M to find 鈥榩ockets鈥 for drug therapies (2024)
- Six CU 抖阴传媒在线 startups selected to present at the Rocky Mountain Life Science Investor Conference (2024)
- Jerome Fox elevated to senior member of prestigious National Academy of Inventors (2024)
- CU 抖阴传媒在线 spinout Think Bioscience raises $17M to target undruggable proteins (2022)
Venture Partners Programs鈥
- Destination Startup (2022)
- Lab Venture Challenge听(2020)
- Intellectual Property Management (2018)
Technology Development Funding
U.S. National Science Foundation (NSF)
听听 听This page was last updated on May 16, 2025. Please email vpnews@colorado.edu for corrections or updates
The Insider Investor E-Newsletter
Media Inquiries
For marketing inquiries and news tips, contact Daniel Leonard,听senior marketing and communications specialist for Venture Partners at CU 抖阴传媒在线.
For media inquiries, please visit .